Last edition
News about "US FDA updates its March 2020 norms to conduct hum"
US FDA updates its March 2020 norms to conduct human studies
The global regulator which noted the Covid-19 as a public health emergency now insists that the clinical trial industry, investigators, and institutional Review Boards need to maintain compliance with good clinical practice (GCP), minimize risks to trial during the ongoing pandemic
US FDA Updates Its March 2020 Norms To Conduct Hum | 06/09/2021 | By Darshana | 237
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members